Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab for Small Bowel Lesions in Psoriasis
NCT01556672Phase 4Completed
- Sponsor
- Innovaderm Research
- Start
- Apr 2012
- Primary completion
- Jan 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in plaque psoriasis, Crohn's disease, sponsored by Innovaderm Research. Started Apr 2012; status: completed.
02
Drugs
03
Conditions
plaque psoriasisCrohn's disease
Beyond the preview
Go deeper on NCT01556672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01556672.